Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Early Intervention, Educational × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 14 Prostatic Neoplasms 13 Colorectal Neoplasms 13 Lung Neoplasms 10 Lymphoma 5 Papillomavirus Infections 4 Hematologic Neoplasms 4 Anatomic Stage I Breast Cancer AJCC v8 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Malignant Solid Neoplasm 3 Hematopoietic and Lymphatic System Neoplasm 3 Triple Negative Breast Neoplasms 2 Skin Carcinoma 2 Ovarian Neoplasms 2 Obesity-Related Malignant Neoplasm 2 Multiple Myeloma 2 Hematopoietic and Lymphoid System Neoplasm 2 Healthy Subject 2 Genital Neoplasms, Female 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Advanced Malignant Solid Neoplasm 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Vorinostat 1 Valganciclovir 1 Thiotepa 1 Therapeutics 1 Tacrolimus 1 Sirolimus 1 Radiotherapy 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Oxaliplatin 1 Nivolumab 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡